Renoprotective Effects of Xanthone Derivatives from Garcinia mangostana Against High Fat Diet and Streptozotocin-Induced Type II Diabetes in Mice

Authors

  • Naymul KARIM Division of Biomedical Sciences, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161
  • Nutjaree JEENDUANG Division of Biomedical Sciences, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161
  • Jitbanjong TANGPONG Division of Biomedical Sciences, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161

DOI:

https://doi.org/10.48048/wjst.2018.2632

Keywords:

Xanthone, Garcinia mangostana, type II diabetes, renoprotection, oxidative stress

Abstract

Diabetes mellitus is described as a metabolic disorder with multiple etiology, characterized by chronic hyperglycemia with disturbances of carbohydrate, fat, and protein metabolisms. Recently, obesity has been identified as a risk factor of developing type II diabetes, at about 80 - 85 %. 1 out of 3 people with type II diabetes develop kidney disease. Garcinia mangostana is used as a traditional medicine in various types of disease, such as abdominal pain, dysentery, wound infections, suppuration, and chronic ulcers. Previous studies have revealed that G. mangostana has good antioxidant, antitumoral, antiallergic, anti-inflammatory, antibacterial, and antiviral activities. In this study, an aqueous extract of xanthone derivative from G. mangostana was used, and the total phenolic content and total antioxidant capacity was assessed. Mice body weight, plasma glucose level, kidney hypertrophy (KI, kidney damage indicator), kidney function test (BUN, CREA), plasma, and kidney tissue melondialdehyde level (MDA, as oxidative damage marker) were evaluated in a high fat diet/streptozotocin (HFD/STZ)-induced type II diabetes mouse model. The results showed that the total phenolic compound in xanthone was 272.62±2.26 µg GAE/mg extract and, in the case of the total antioxidant capacity, % of inhibition of xanthone was 88.40±0.25 µmol TEAC/mg extract, respectively. This has significant correlation (R2 = 0.9777) to the total phenolic content. In the in vivo study, increased body weight, plasma glucose level, kidney hypertrophy, plasma kidney profile, plasma, and kidney tissue melondialdehyde levels were significantly increased (P < 0.05) in the HFD/STZ-induced type II diabetes mouse model. Co-treatment with xanthone significantly (P < 0.05) improved all of the biochemical parameters and body weight in the mouse model. Taken together, the results indicate that xanthone possesses a potent renoprotective effect in type II diabetes mice.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biography

Naymul KARIM, Division of Biomedical Sciences, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161

School of Allied Health Science and Public Health

References

JE Shaw, RA Sicree and PZ Zimmet. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010; 87, 4-14.

AH Mokdad, BA Bowman, ES Ford, F Vinicor, JS Marks and JP Koplan. The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc. 2001; 286, 1195-200.

M Kasuga. Insulin resistance and pancreatic beta cell failure. J. Clin. Invest. 2006; 116, 1756-60.

R Singh, A Barden, T Mori and L Beilin. Advanced glycation endproducts: A review. Diabetologia 2001; 44, 129-46.

T Nishikawa, D Edelstein, XL Du, S Yamagishi, T Matsumura, Y Kaneda, MA Yorek, D Beebe, PJ Oates, HP Hammes, I Giardino and M Brownlee. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404, 787-90.

C Yabe-Nishimura. Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998; 50, 21-33.

D Koya and GL King. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47, 859-66.

V Jakus. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl. Med. J. 2000; 101, 541-51.

T Miyata. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis (“carbonyl stress”). Bull. Mem. Acad. R. Med. Belg. 2002; 157, 189-98.

D Bonnefont-Rousselot, JP Bastard, MC Jaudon and J Delattre. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 2000; 26, 163-76.

IC West. Radicals and oxidative stress in diabetes. Diabetes Med. 2000; 17, 171-80.

T Blanco-Ayala, R Lugo-Huitron, EM Serrano-Lopez, R Reyes-Chilpa and E Rangel-Lopez. Antioxidant properties of xanthones from Calophyllumbrasiliense: Prevention of oxidative damage induced by FeSO4. BMC Compl. Altern. Med. 2013; 13, 262.

LG Chen, LL Yang and CC Wang. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 208; 46, 688-93.

DJ Jiang, Z Dai and YJ Li. Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc. Drug Rev. 2004; 22, 91-102.

MP Phyu and J Tangpong. Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment. Food Chem. Toxicol. 2014; 70, 151-6.

T Sathishkumar and R Baskar. Renoprotective effect of Tabernaemontana heyneana Wall. leaves against paracetamol-induced renotoxicity in rats and detection of polyphenols by high-performance liquid chromatography-diode array detector-mass spectrometry analysis. J. Acute Med. 2014; 4, 57-67.

J Trujillo, YI Chirino, E Molina-Jijon, AC Andérica-Romero, E Tapia and J Pedraza-Chaverrí. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013; 1, 448-56.

LA Ahmed. Renoprotective effect of Egyptian cape gooseberry fruit (Physalisperuviana L.) against acute renal injury in rats. Sci. World J. 2014; 2014, 7.

JM Pérez-Rojas, C Cruz, P García-López, DJ Sánchez-González, CM Martínez-Martínez, G Ceballos, M Espinosa, J Meléndez-Zajgla and J Pedraza-Chaverri. Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic. Res. 2009; 43, 1122-32.

K Jarukamjorn, T Lao-ong and W Chatuphonprasert. Diabetic induction in experimental mouse model. Thai Pharm. Health Sci. J. 2011; 6, 229-39.

O Kaisoon, S Siriamornpun, N Weerapreeyakul and N Meeso. Phenolic compounds and antioxidant activities of edible flowers from Thailand. J. Funct. Foods 2011; 3, 88-99.

R Re, N Pellegrini, A Proteggente, A Pannala, M Yang and C Rice-Evans. antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999; 26, 1231-7.

T Manaer, L Yu, Y Zhang, XJ Xiao and XH Nabi. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin. J. Ethnopharmacol. 2015; 169, 269-74.

R Ceci, MRB Valls, G Duranti, I Dimauro, F Quaranta, M Pittaluga, S Sabatini, P Caserotti, P Parisi, A Parisi and D Caporossi. Oxidative stress responses to a graded maximal exercise test in older adults following explosive-type resistance training. Redox Biol. 2014; 2, 65-72.

M Goulart, MC Batoru and AS Rodrigues. Lipoperoxidation production and thiol antioxidant in chromium exposed worker. Mutagenesis 2005; 20, 311-5.

Y Huang, E Chen and Y Chen. Establishment a rat model for non-insulin-dependent diabetes mellitus induced by streptozotocin in combination with high-sugar and high-fat diets. J. Pract. Med. 2010; 26, 2299-301.

F Gutierrez-Orozco and ML Failla. Biological activities and bioavailability of mangosteen xanthones: A critical review of the current evidence. Nutrients 2013; 5, 3163-83.

C Jiang, L Liang and Y Guo. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacol. Sin. 2012; 33, 1217-45.

C Chitchumroonchokchai, KM Riedl, S Suksumrarn, SK Clinton, AD Kinghorn and ML Failla. Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J. Nutr. 2012; 142, 675-80.

M Taher, MZAM Amiroudine, TMFST Zakaria, D Susanti and SJA Ichwan. α-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPARγ, GLUT4, and leptin expressions. Evid. Based Compl. Alternative Med. 2015; 2015, 740238.

T Yokozawa, JS Noh and CH Park. Green tea polyphenols for the protection against renal damage caused by oxidative stress. Evid. Based Compl. Alternative Med. 2012; 2012, 845917.

K Susztak, AC Raff, M Schiffer and EP Bottinger. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006; 55, 225-33.

O Aouacheri, S Saka, M Krim, A Messaadia and I Maidi. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can. J. Diabetes 2015; 39, 44-9.

K Kedziora-Kornatowska, S Szram, T Kornatowski, L Szadujkis-Szadurski, J Kedziora and G Bartosz. The effect of verapamil on the antioxidant defence system in diabetic kidney. Clin. Chim. Acta 2002; 322, 105-12.

N Kashihara, Y Haruna, VK Kondeti and YS Kanwar. Oxidative stress in diabetic nephropathy. Curr. Med. Chem. 2010; 17, 4256-69.

DJ Son, SY Hwang, MH Kim, UK Park and BS Kim. Anti-diabetic and hepato-renal protective effects of Ziyuglycoside II methyl ester in type 2 diabetic mice. Nutrients 2015; 7, 5469-83.

T Inoguchi, P Li, F Umeda, HY Yu, M Kakimoto, M Imamura, T Aoki, T Etoh, T Hashimoto, M Naruse, H Sano, H Utsumi and H Nawata. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49, 1939-45.

NA Qinna and AA Badwan. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des. Devel. Ther. 2015; 9, 2515-25.

Downloads

Published

2016-12-16

How to Cite

KARIM, N., JEENDUANG, N., & TANGPONG, J. (2016). Renoprotective Effects of Xanthone Derivatives from Garcinia mangostana Against High Fat Diet and Streptozotocin-Induced Type II Diabetes in Mice. Walailak Journal of Science and Technology (WJST), 15(2), 107–116. https://doi.org/10.48048/wjst.2018.2632

Issue

Section

Research Article